Results BPC-157 accelerates wound closure in alkali-burned rats During the study, no abnormalities were observed in the general condition and behavior of rats in all treatment cohorts, including asitia, nausea, diarrhea, cough, or weight loss, and no symptoms of allergic response such as hydroposia or localized rash occurred in animals receiving bFGF or BPC-157
For the coated tablet form, the patient should take the tablet with plain water, either before or after meals, and must not crush or chew the tablet
Bilirubin binding to research-subject liver ligandin (glutathione S-transferase)
A widely referenced compound in dermatological and tissue regeneration research literature
The treatment also works to speed up your metabolism, helping with weight loss and is used to prevent or treat a Vitamin B12 deficiency